- In October 2024, Siemens Healthineers announced its collaboration with over 20 industry and public partners, including seven prominent stroke hospitals, to enhance stroke management for patients throughout Europe. The five-year 'UMBRELLA' project, with a total budget of USD 29.30 million, is being funded in part by the Innovative Health Initiative (IHI), a public-private partnership aimed at health research and innovation between the European Union and the life sciences sector in Europe, as well as contributions from industry partners involved in the consortium
- In September 2024, Michigan-based medical device leader Stryker has finalized its acquisition of the Nico Corporation to enhance its neurotechnology and stroke care portfolio. This acquisition includes systems specifically designed for managing surgeries to treat intracerebral hemorrhages (ICH), known as BrainPath and Myriad. By integrating Nico's innovative technologies, Stryker aims to strengthen its offerings in the neurotechnology sector and improve treatment options for patients suffering from stroke-related conditions
- In August 2024, Christian Medical College (CMC) Vellore and IIT Madras unveiled a portable robotic device called PLUTO (Plug-and-Train Robot for Hand Neurorehabilitation) aimed at assisting stroke survivors in their recovery through hand movement therapy. This innovative device is crafted to be both affordable and user-friendly, ensuring accessibility for use in diverse environments such as hospitals, small clinics, community centers, and even at home
- In February 2024, Basking Biosciences, a clinical-stage biopharmaceutical company focused on developing an innovative acute thrombolytic therapy for stroke treatment, announced the completion of a USD 55 million financing round. The round was led by new investor ARCH Venture Partners, with contributions from other new investors including Insight Partners, Platanus, Solas BioVentures, and RTW Investments, alongside existing investors Longview Ventures, Rev1 Ventures, and The Ohio State University
- In May 2022, researchers at Osaka Metropolitan University began exploring robotic therapy as a promising treatment for stroke recovery during its chronic stage. If widely adopted, robotic therapy could enhance stroke patient care by offering a cost-effective solution with minimal need for direct supervision from therapeutic staff
- In April 2022, the U.S. National Institutes of Health (NIH) provided USD 1.8 million in funding for a project aimed at developing artificially grown, simplified mini-organs. These brain-like miniature organs are intended to produce particles that could be harvested for creating new medications targeting brain cells damaged by stroke
Frequently Asked Questions
The market is segmented based on Segmentation By Type (Ischemic Stroke, Transient Ischemic Attack (TIA), and Hemorrhage Stroke), Treatment (Medication, Surgery, and Other Therapy), Diagnosis (Imaging Test, Blood Test, Echocardiogram, Lumbar Puncture, and Other), Gender (Female and Male), End User (Hospitals & Clinics, Specilaty Clinics, Ambulatory Surgical Centers, Homecare, Laboratories, and Others), Distribution Channel (Direct, Retail and Online) – Industry Trends and Forecast to 2031
.
The Global Stroke Market size was valued at USD 32.57 USD Thousand in 2023.
The Global Stroke Market is projected to grow at a CAGR of 7.5% during the forecast period of 2024 to 2031.
The major players operating in the market include Bayer AG, F. Hoffmann La Roche Ltd, Boehringer Ingelheim International GmbH, Sanofi, Bristol Myers Squibb Company, Johnson & Johnson Services , Medtronic, Teva Pharmaceuticals USA , Pfizer , AstraZeneca, Viatris , Lupin, Abbott, DAIICHI SANKYO COMPANY LIMITED, Penumbra , Oxford Laboratories Pvt. , Sandoz Group AG, GLENMARK PHARMACEUTICALS , Fresenius SE & Co. KGaA, Amneal Pharmaceuticals LLC.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
